RIGI and cancer: To investigate the role of RNA polymerase III in the RIG-I signaling pathway in human cancer cells, PANC-1 and A549 cells were treated with the RNA polymerase III inhibitor ML-60218, and the expression of IFN-β induced by Poly(dA:dT) was determined.